Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Lannett Company, Inc. with status Current. The shortage was first posted on 07/14/2023.
Shortage Details
- Status
- Current
- Company
- Lannett Company, Inc.
- Package NDC
- 0527-4663-37
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)
- Initial Posting
- 07/14/2023
- Revised Date